The race to become Catalonia reference pillar for research, development and innovation (officially this Wednesday) has reached another level. AstraZeneca will invest approximately 800 million euros to place R&D Centerbecoming the leading company in the industry. largest foreign investment operation for this purpose in the region. According to the information put forward after the meeting last Monday, State, the move will involve hiring 1,000 people over the next five years. That’s the goal, as announced this Wednesday. main European headquarters within the company. And apart from that world reference center in research and innovation.
he told like this President of AstraZeneca in Spain, Rick R SuarezAn iconic event was held at the official launch of the project. Glories Tower (on the day it is proposed as a center European Medicines Agency) and received the participation and assistance of numerous public figures and pharmaceutical company executives. Among the previous ones, for example, Research General Secretary of the Ministry of Science and Innovation, rachel yotti; HE ‘President’ of the Generalitat of Catalonia, Father Aragones; wave Agenda 2030 Deputy Mayor, Laia Bonet.
“We clearly see that the time has come to innovate here, we are at a key moment as a country and we are positioning ourselves on the international stage. biomedical research” reassured the director of AstraZeneca regarding the trident that motivates the location of this center in the city: research capacity, clinical quality And prepared professionals. “We defended this country as the best country to make this investment and we managed to convince AstraZeneca of it, but I feel a great responsibility to show that we can do it and for that, Suárez acknowledges the commitment of the Spanish Government, Catalonia and other autonomous communities to achieve the goals of this ‘centre’. started it,” he said.
Solutions and treatments
Some details about the center were also revealed at the event. The plan is for it to be located in the same building that currently houses the Alexion headquarters (AstraZeneca’s arm dedicated to clinical trials on rare diseases). The upper part of the Diagonal in Barcelonaand basically doing research and innovation here to develop relevant solutions and find treatments. cancer, kidney and cardiovascular problemsHE Respiratory system anyone rare diseasesand progress has been made in the field. immunotherapy And vaccines.
“This ‘center’ will help increase the presence of Spain and Spanish centers in global research, and in this way we will not only increase the number of clinical trials, but also conduct studies at earlier and more relevant stages,” he said. underlined Alexion VP of Clinical Development And In charge of the new AstraZeneca ‘headquarters’ in Barcelona, Gonzalo de Miquel. “This will allow us to advance science and medicine from Spain to the world,” he said.
Source: Informacion
James Sean is a writer for “Social Bites”. He covers a wide range of topics, bringing the latest news and developments to his readers. With a keen sense of what’s important and a passion for writing, James delivers unique and insightful articles that keep his readers informed and engaged.